Toyoda H - Search Results

1

Anti-tumor effect of Huaier extract against neuroblastoma cells in vitro.

Xu DQ, Yuan XJ, Toyoda H, Hirayama M. Xu DQ, et al. Among authors: toyoda h. Int J Med Sci. 2021 Jan 1;18(4):1015-1023. doi: 10.7150/ijms.48219. eCollection 2021. Int J Med Sci. 2021. PMID: 33456359 Free PMC article.

2

Toyoda H, Azuma E, Hori H, Hirayama M, Kobayashi M, Isogai K, Kondo N, Komada Y. Toyoda H, et al. Bone Marrow Transplant. 2001 Aug;28(4):413-5. doi: 10.1038/sj.bmt.1703156. Bone Marrow Transplant. 2001. PMID: 11571517

3

Experimental treatment of human neuroblastoma using live-attenuated poliovirus.

Toyoda H, Ido M, Hayashi T, Gabazza EC, Suzuki K, Kisenge RR, Kang J, Hori H, Komada Y. Toyoda H, et al. Int J Oncol. 2004 Jan;24(1):49-58. Int J Oncol. 2004. PMID: 14654940

4

A case of juvenile myelomonocytic leukemia with concomitant cytomegalovirus infection.

Toyoda H, Ido M, Hori H, Hiraiwa H, Hirayama M, Kobayashi M, Ogawa M, Miyahara M, Iwamoto S, Hayashi T, Gabazza EC, Suzuki K, Azuma E, Komada Y. Toyoda H, et al. J Pediatr Hematol Oncol. 2004 Sep;26(9):606-8. doi: 10.1097/01.mph.0000133599.34635.90. J Pediatr Hematol Oncol. 2004. PMID: 15342990

5

Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model.

Araki M, Hirayama M, Azuma E, Kumamoto T, Iwamoto S, Toyoda H, Ito M, Amano K, Komada Y. Araki M, et al. Among authors: toyoda h. J Immunol. 2010 Dec 15;185(12):7739-45. doi: 10.4049/jimmunol.1001226. Epub 2010 Nov 15. J Immunol. 2010. PMID: 21078914

6

Elevated numbers of cells producing interleukin-5 and interleukin-10 in a boy with Kimura disease.

Hosoki K, Hirayama M, Kephart GM, Kita H, Nagao M, Uchizono H, Toyoda H, Senba Y, Imai Y, Komada Y, Ihara T, Fujisawa T. Hosoki K, et al. Among authors: toyoda h. Int Arch Allergy Immunol. 2012;158 Suppl 1:70-4. doi: 10.1159/000337777. Epub 2012 May 15. Int Arch Allergy Immunol. 2012. PMID: 22627370

7

Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease.

Hirayama M, Azuma E, Nakazawa A, Iwamoto S, Toyoda H, Komada Y. Hirayama M, et al. Among authors: toyoda h. Int J Hematol. 2013 Apr;97(4):529-34. doi: 10.1007/s12185-013-1279-y. Epub 2013 Feb 3. Int J Hematol. 2013. PMID: 23378184

8

Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura.

Toyoda H, Azuma E, Kawasaki Y, Iwasa T, Ohashi H, Otsuki S, Iwamoto S, Hirayama M, Itoh-Habe N, Wada H, Kondo M, Keida Y, Ito T, Komada Y. Toyoda H, et al. J Allergy Clin Immunol. 2013 Jul;132(1):226-7. doi: 10.1016/j.jaci.2013.01.040. Epub 2013 Mar 14. J Allergy Clin Immunol. 2013. PMID: 23498591 No abstract available.

9

Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male.

Toyoda H, Hirayama J, Sugimoto Y, Uchida K, Ohishi K, Hirayama M, Komada Y. Toyoda H, et al. Pediatrics. 2014 Jun;133(6):e1787-91. doi: 10.1542/peds.2013-2419. Epub 2014 May 12. Pediatrics. 2014. PMID: 24819565

10

Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation.

Tanimura M, Dohi K, Hirayama M, Sato Y, Sugiura E, Nakajima H, Kanemitsu S, Toyoda H, Yamada N, Masuya M, Imanaka-Yoshida K, Shimpo H, Azuma E, Ito M. Tanimura M, et al. Among authors: toyoda h. Int J Cardiol. 2015 Oct 1;196:88-90. doi: 10.1016/j.ijcard.2015.05.183. Epub 2015 Jun 4. Int J Cardiol. 2015. PMID: 26080282 No abstract available.

11

PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells.

Qi L, Toyoda H, Xu DQ, Zhou Y, Sakurai N, Amano K, Kihira K, Hori H, Azuma E, Komada Y. Qi L, et al. Among authors: toyoda h. Cancer Cell Int. 2015 Sep 29;15:91. doi: 10.1186/s12935-015-0239-4. eCollection 2015. Cancer Cell Int. 2015. PMID: 26421002 Free PMC article.

12

Erratum to: PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells.

Qi L, Toyoda H, Xu DQ, Zhou Y, Sakurai N, Amano K, Kihira K, Hori H, Azuma E, Komada Y. Qi L, et al. Among authors: toyoda h. Cancer Cell Int. 2015 Nov 17;15:108. doi: 10.1186/s12935-015-0261-6. eCollection 2015. Cancer Cell Int. 2015. PMID: 26581614 Free PMC article.

13

Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.

Toyoda H, Wada H, Miyata T, Amano K, Kihira K, Iwamoto S, Hirayama M, Komada Y. Toyoda H, et al. J Pediatr Hematol Oncol. 2016 Apr;38(3):e137-9. doi: 10.1097/MPH.0000000000000505. J Pediatr Hematol Oncol. 2016. PMID: 26840081

14

Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.

Yodoya N, Iwamoto S, Matsumine A, Azuma E, Toyoda H, Miura Y, Nakatani K, Imai H, Hirayama M, Komada Y. Yodoya N, et al. Among authors: toyoda h. J Pediatr Hematol Oncol. 2017 Jan;39(1):6-9. doi: 10.1097/MPH.0000000000000721. J Pediatr Hematol Oncol. 2017. PMID: 27918348

15

Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo.

Xu DQ, Toyoda H, Yuan XJ, Qi L, Chelakkot VS, Morimoto M, Hanaki R, Kihira K, Hori H, Komada Y, Hirayama M. Xu DQ, et al. Among authors: toyoda h. Exp Cell Res. 2018 Apr 15;365(2):177-184. doi: 10.1016/j.yexcr.2018.02.032. Epub 2018 Feb 28. Exp Cell Res. 2018. PMID: 29499203

16

Induction of MEK/ERK activity by AZD8055 confers acquired resistance in neuroblastoma.

Xu DQ, Toyoda H, Qi L, Morimoto M, Hanaki R, Iwamoto S, Komada Y, Hirayama M. Xu DQ, et al. Among authors: toyoda h. Biochem Biophys Res Commun. 2018 May 15;499(3):425-432. doi: 10.1016/j.bbrc.2018.03.143. Epub 2018 Mar 30. Biochem Biophys Res Commun. 2018. PMID: 29571732

17

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan.

Matsumoto T, Toyoda H, Amano K, Hirayama M, Ishikawa E, Fujimoto M, Ito M, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Kawamura N, Ikejiri M, Kawakami K, Miyata T, Wada H. Matsumoto T, et al. Among authors: toyoda h. Clin Appl Thromb Hemost. 2018 Nov;24(8):1301-1307. doi: 10.1177/1076029618771750. Epub 2018 Apr 25. Clin Appl Thromb Hemost. 2018. PMID: 29695177 Free PMC article. Clinical Trial.

18

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab: comment.

Matsumoto T, Wada H, Toyoda H, Hirayama M, Yamashita Y, Katayama N. Matsumoto T, et al. Among authors: toyoda h. J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14190. Online ahead of print. J Thromb Haemost. 2018. PMID: 29877044 Free article. No abstract available.

19

Weekly Rituximab Followed by Monthly Rituximab Treatment for Autoimmune Disease Associated With RAS-associated Autoimmune Leukoproliferative Disease.

Toyoda H, Deguchi T, Iwamoto S, Kihira K, Hori H, Komada Y, Hirayama M. Toyoda H, et al. J Pediatr Hematol Oncol. 2018 Nov;40(8):e516-e518. doi: 10.1097/MPH.0000000000001276. J Pediatr Hematol Oncol. 2018. PMID: 30080751

20

Discontinuation of NTBC after liver transplantation in tyrosinemia type 1.

Kurihara K, Toyoda H, Amoano K, Inoue M, Uchida K, Sakurai H, Hayashi A, Hirayama M. Kurihara K, et al. Among authors: toyoda h. Pediatr Int. 2018 Nov;60(11):1039-1041. doi: 10.1111/ped.13697. Epub 2018 Oct 30. Pediatr Int. 2018. PMID: 30375135 No abstract available.

21

Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.

Takada A, Ii N, Hirayama M, Toyoda H, Matsubara T, Toyomasu Y, Kawamura T, Daimon T, Sakuma H, Nomoto Y. Takada A, et al. Among authors: toyoda h. J Neurosurg Pediatr. 2019 Mar 1;23(3):317-324. doi: 10.3171/2018.9.PEDS18181. Epub 2018 Nov 23. J Neurosurg Pediatr. 2019. PMID: 30497152

22

CD3+ B-1a Cells as a Mediator of Disease Progression in Autoimmune-Prone Mice.

Yamamoto W, Toyoda H, Xu DQ, Hanaki R, Morimoto M, Nakato D, Ito T, Iwamoto S, Bonno M, Tanaka S, Hirayama M. Yamamoto W, et al. Among authors: toyoda h. Mediators Inflamm. 2018 Dec 23;2018:9289417. doi: 10.1155/2018/9289417. eCollection 2018. Mediators Inflamm. 2018. PMID: 30670930 Free PMC article.

23

Report of 2 Pediatric Cases With Li-Fraumeni Syndrome Related Malignancy in a Family.

Takeoka M, Toyoda H, Hirayama J, Suzuki N, Hanaki R, Amano K, Iwamoto S, Hirayama M. Takeoka M, et al. Among authors: toyoda h. J Pediatr Hematol Oncol. 2021 May 1;43(4):e567-e570. doi: 10.1097/MPH.0000000000001862. J Pediatr Hematol Oncol. 2021. PMID: 32555031

24

Refractory Ileal Perforations in a Cytomegalovirus-Infected Premature Neonate Resolved After Ganciclovir Therapy.

Morimoto M, Sawada H, Yodoya N, Ohashi H, Toriyabe K, Hanaki R, Sugiura K, Toyoda H, Matsushita K, Koike Y, Otake K, Inoue M, Uchida K, Imai H, Mitani Y, Maruyama K, Komada Y, Ikeda T, Hirayama M. Morimoto M, et al. Among authors: toyoda h. Front Pediatr. 2020 Jul 14;8:352. doi: 10.3389/fped.2020.00352. eCollection 2020. Front Pediatr. 2020. PMID: 32760683 Free PMC article.

25

Huaier Extract Induces Apoptosis in Hepatoblastoma Cells Via the MEK/ERK Signaling Pathway.

Xu DQ, Yuan XJ, Hirayama M, Toyoda H. Xu DQ, et al. Among authors: toyoda h. In Vivo. 2020 Sep-Oct;34(5):2381-2388. doi: 10.21873/invivo.12051. In Vivo. 2020. PMID: 32871763 Free PMC article.

26

Case Report: Effects of Secondary Hyperparathyroidism Treatment on Improvement of Juvenile Nephronophthisis-Induced Pancytopenia and Myelofibrosis.

Amano K, Toyoda H, Nishikawa K, Murata T, Hirayama M. Amano K, et al. Among authors: toyoda h. Front Pediatr. 2021 May 11;9:550158. doi: 10.3389/fped.2021.550158. eCollection 2021. Front Pediatr. 2021. PMID: 34046371 Free PMC article.

27

Donor-derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation.

Hanaki R, Toyoda H, Iwamoto S, Morimoto M, Nakato D, Ito T, Niwa K, Amano K, Hashizume R, Tawara I, Hirayama M. Hanaki R, et al. Among authors: toyoda h. Immun Inflamm Dis. 2021 Dec;9(4):1489-1499. doi: 10.1002/iid3.503. Epub 2021 Aug 19. Immun Inflamm Dis. 2021. PMID: 34410039 Free PMC article.

28

Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibition.

Morimoto M, Toyoda H, Niwa K, Hanaki R, Okuda T, Nakato D, Amano K, Iwamoto S, Hirayama M. Morimoto M, et al. Among authors: toyoda h. Mol Clin Oncol. 2022 Jul 21;17(3):138. doi: 10.3892/mco.2022.2571. eCollection 2022 Sep. Mol Clin Oncol. 2022. PMID: 35949892 Free PMC article.

29

Autonomic Nervous System in Preterm Very Low Birth Weight Neonates with Intraventricular Hemorrhage.

Shiono A, Bonno M, Toyoda H, Ogawa M, Tanaka S, Hirayama M. Shiono A, et al. Among authors: toyoda h. Am J Perinatol. 2024 May;41(S 01):e577-e583. doi: 10.1055/a-1926-0335. Epub 2022 Aug 17. Am J Perinatol. 2024. PMID: 35977712

30

Successful hematopoietic stem cell transplantation for two patients with relapse of intrachromosomal amplification of chromosome 21-positive B-cell precursor acute lymphoblastic leukemia.

Harada T, Toyoda H, Tsuboya N, Hanaki R, Amano K, Hirayama M. Harada T, et al. Among authors: toyoda h. Front Pediatr. 2022 Sep 8;10:960126. doi: 10.3389/fped.2022.960126. eCollection 2022. Front Pediatr. 2022. PMID: 36160794 Free PMC article.

31

Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model.

Nakato D, Iwamoto S, Amano K, Ito T, Toyoda H, Hanaki R, Morimoto M, Niwa K, Tawara I, Imanaka-Yoshida K, Ogawa M, Hirayama M. Nakato D, et al. Among authors: toyoda h. Mediators Inflamm. 2023 Jan 31;2023:6316581. doi: 10.1155/2023/6316581. eCollection 2023. Mediators Inflamm. 2023. PMID: 36762286 Free PMC article.

32

Case report: Thyroid storm in a three-year-old girl presenting with febrile status epilepticus and hypoglycemia.

Aoki Y, Hanaki R, Toyoda H, Emori K, Miyahara M, Hirayama M. Aoki Y, et al. Among authors: toyoda h. Front Pediatr. 2023 Jun 16;11:1213040. doi: 10.3389/fped.2023.1213040. eCollection 2023. Front Pediatr. 2023. PMID: 37397147 Free PMC article.

33

Secondary malignancy after carbon ion radiotherapy in a 15-year-old female with Ewing sarcoma.

Ushida E, Toyoda H, Hanaki R, Amano K, Okamoto M, Yamada S, Nojima T, Hirayama M. Ushida E, et al. Among authors: toyoda h. Pediatr Blood Cancer. 2023 Dec;70(12):e30676. doi: 10.1002/pbc.30676. Epub 2023 Sep 13. Pediatr Blood Cancer. 2023. PMID: 37705147 No abstract available.

34

Case Report: MYH9-related disease caused by Ala44Pro mutation in a child with a previous diagnosis of chronic immune thrombocytopenia.

Niwa K, Toyoda H, Kohso A, Okumura Y, Kunishima S, Hirayama M. Niwa K, et al. Among authors: toyoda h. Front Pediatr. 2024 May 17;12:1391742. doi: 10.3389/fped.2024.1391742. eCollection 2024. Front Pediatr. 2024. PMID: 38827217 Free PMC article.

35

Activation-induced T cell death occurs at G1A phase of the cell cycle.

Li QS, Tanaka S, Kisenge RR, Toyoda H, Azuma E, Komada Y. Li QS, et al. Among authors: toyoda h. Eur J Immunol. 2000 Nov;30(11):3329-37. doi: 10.1002/1521-4141(200011)30:11<3329::AID-IMMU3329>3.0.CO;2-#. Eur J Immunol. 2000. PMID: 11093149 Free article.

36

Expression of short-form caspase 8 correlates with decreased sensitivity to Fas-mediated apoptosis in neuroblastoma cells.

Kisenge RR, Toyoda H, Kang J, Tanaka S, Yamamoto H, Azuma E, Komada Y. Kisenge RR, et al. Among authors: toyoda h. Cancer Sci. 2003 Jul;94(7):598-605. doi: 10.1111/j.1349-7006.2003.tb01489.x. Cancer Sci. 2003. PMID: 12841868 Free PMC article.

37

Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.

Atsumi S, Matsumine A, Toyoda H, Niimi R, Iino T, Nakamura T, Matsubara T, Asanuma K, Komada Y, Uchida A, Sudo A. Atsumi S, et al. Among authors: toyoda h. Int J Oncol. 2012 Sep;41(3):893-902. doi: 10.3892/ijo.2012.1514. Epub 2012 Jun 12. Int J Oncol. 2012. PMID: 22692919

38

Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.

Qi L, Toyoda H, Shankar V, Sakurai N, Amano K, Kihira K, Iwasa T, Deguchi T, Hori H, Azuma E, Gabazza EC, Komada Y. Qi L, et al. Among authors: toyoda h. Cancer Sci. 2013 Sep;104(9):1162-71. doi: 10.1111/cas.12204. Epub 2013 Jun 25. Cancer Sci. 2013. PMID: 23710710 Free PMC article.

39

Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines.

Shankar V, Hori H, Kihira K, Lei Q, Toyoda H, Iwamoto S, Komada Y. Shankar V, et al. Among authors: toyoda h. PLoS One. 2015 Mar 16;10(3):e0120069. doi: 10.1371/journal.pone.0120069. eCollection 2015. PLoS One. 2015. PMID: 25774696 Free PMC article.

40

FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group.

Kumamoto T, Goto H, Ogawa C, Hori T, Deguchi T, Araki T, Saito AM, Manabe A, Horibe K, Toyoda H. Kumamoto T, et al. Among authors: toyoda h. Int J Hematol. 2020 Nov;112(5):720-724. doi: 10.1007/s12185-020-02962-2. Epub 2020 Aug 6. Int J Hematol. 2020. PMID: 32761462 Clinical Trial.

41

Multiple cutaneous squamous cell carcinomas in a patient with interferon gamma receptor 2 (IFN gamma R2) deficiency.

Toyoda H, Ido M, Nakanishi K, Nakano T, Kamiya H, Matsumine A, Uchida A, Mizutani H, de Beaucoudrey L, Vogt G, Boisson-Dupuis S, Bustamante J, Casanova JL, Komada Y. Toyoda H, et al. J Med Genet. 2010 Sep;47(9):631-4. doi: 10.1136/jmg.2009.072108. Epub 2010 Jun 28. J Med Genet. 2010. PMID: 20587411

42

Phosphoinositide 3-kinase induced activation and cytoskeletal translocation of protein kinase CK2 in protease activated receptor 1-stimulated platelets.

Nakanishi K, Toyoda H, Tanaka S, Yamamoto H, Komada Y, Gabazza EC, Hayashi T, Suzuki K, Ido M. Nakanishi K, et al. Among authors: toyoda h. Thromb Res. 2010 Dec;126(6):511-6. doi: 10.1016/j.thromres.2010.09.016. Epub 2010 Nov 4. Thromb Res. 2010. PMID: 21055793

43

Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome.

Ito-Habe N, Wada H, Matsumoto T, Ohishi K, Toyoda H, Ishikawa E, Nomura S, Komada Y, Ito M, Nobori T, Katayama N. Ito-Habe N, et al. Among authors: toyoda h. Int J Hematol. 2011 Jan;93(1):47-52. doi: 10.1007/s12185-010-0732-4. Epub 2010 Dec 9. Int J Hematol. 2011. PMID: 21153061

44

Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group.

Kumamoto T, Goto H, Ogawa C, Hori T, Deguchi T, Araki T, Saito AM, Manabe A, Horibe K, Toyoda H. Kumamoto T, et al. Among authors: toyoda h. Int J Hematol. 2021 Feb;113(2):308-309. doi: 10.1007/s12185-020-03077-4. Int J Hematol. 2021. PMID: 33484418 No abstract available.

45

Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines.

Kang J, Kisenge RR, Toyoda H, Tanaka S, Bu J, Azuma E, Komada Y. Kang J, et al. Among authors: toyoda h. Br J Haematol. 2003 Dec;123(5):921-32. doi: 10.1046/j.1365-2141.2003.04699.x. Br J Haematol. 2003. PMID: 14632785 Free article.

46

TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.

Ueki H, Ogawa C, Goto H, Nishi M, Yamanaka J, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Igarashi S, Sato A, Hori T, Saito AM, Watanabe T, Deguchi T, Manabe A, Horibe K, Toyoda H. Ueki H, et al. Among authors: toyoda h. Int J Hematol. 2024 Apr;119(4):450-458. doi: 10.1007/s12185-024-03710-6. Epub 2024 Jan 25. Int J Hematol. 2024. PMID: 38267673

47

Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.

Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T. Matsumoto T, et al. Among authors: toyoda h. Int J Hematol. 2014 Nov;100(5):437-42. doi: 10.1007/s12185-014-1655-2. Epub 2014 Aug 19. Int J Hematol. 2014. PMID: 25135378

48

Prognostic significance of CD155 mRNA expression in soft tissue sarcomas.

Atsumi S, Matsumine A, Toyoda H, Niimi R, Iino T, Sudo A. Atsumi S, et al. Among authors: toyoda h. Oncol Lett. 2013 Jun;5(6):1771-1776. doi: 10.3892/ol.2013.1280. Epub 2013 Apr 2. Oncol Lett. 2013. PMID: 23833639 Free PMC article.

49

Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.

Miyagawa N, Goto H, Ogawa A, Kikuta A, Kosaka Y, Sekimizu M, Tomizawa D, Toyoda H, Hiramatsu H, Hara J, Mochizuki S, Nakayama H, Yoshimura K, Iijima-Yamashita Y, Sanada M, Ogawa C. Miyagawa N, et al. Among authors: toyoda h. Int J Hematol. 2023 Aug;118(2):267-276. doi: 10.1007/s12185-023-03609-8. Epub 2023 May 1. Int J Hematol. 2023. PMID: 37127801 Clinical Trial.

50

Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children's Cancer Group.

Goto H, Kada A, Ogawa C, Nishiuchi R, Yamanaka J, Iguchi A, Nishi M, Sakaguchi K, Kumamoto T, Mochizuki S, Ueki H, Kosaka Y, Saito AM, Toyoda H. Goto H, et al. Among authors: toyoda h. Int J Hematol. 2024 Aug 27. doi: 10.1007/s12185-024-03838-5. Online ahead of print. Int J Hematol. 2024. PMID: 39190256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,474 results

Search Page